Aminosalicylic acid indications and usage: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:




 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = PASER (AMINOSALICYLIC ACID) GRANULE, DELAYED RELEASE [JACOBUS PHARMACEUTICAL COMPANY, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6f2753dc-5f0c-4f49-9335-e519afb69ba6 | publisher =  | date =  | accessdate =  }}</ref>
==References==
==References==
{{Reflist}}
{{Reflist}}

Revision as of 15:55, 24 December 2013

Aminosalicylic Acid
PASER® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Chetan Lokhande, M.B.B.S [2]


[1]

References

  1. "PASER (AMINOSALICYLIC ACID) GRANULE, DELAYED RELEASE [JACOBUS PHARMACEUTICAL COMPANY, INC.]".

Adapted from the FDA Package Insert.